腹股沟疝注射硬化剂后的手术难点  被引量:2

Operation difficulties of inguinal hernia after sclerotherapy

在线阅读下载全文

作  者:邓文杰 秦青平 夏玉春 

机构地区:[1]华润武钢总医院普外科,武汉430080

出  处:《腹部外科》2015年第5期356-359,共4页Journal of Abdominal Surgery

摘  要:目的 探讨无张力疝修补术治疗曾行硬化剂"注射治疗"无效的腹股沟疝的治疗效果及硬化剂"注射治疗"对手术治疗腹股沟疝的影响.方法 回顾性分析2011年1月至2014年2月曾行硬化剂"注射治疗"的34例病人行无张力疝修补术的临床资料,其中33例采用无张力疝修补术(Lichtenstein),1例采用腹腔镜全腹膜外腹股沟疝修补术(totally extraperitoneal prosthesic,TEP).结果 34例病人手术均获得成功,1例TEP中转行Lichtenstein手术,所有病人均获痊愈,手术时间为60~120 min.术后随访1~4年均无复发.结论 Lichtenstein手术治疗硬化剂"注射治疗"无效的腹股沟疝具有创伤小、操作简单、并发症低等优势,可作为首选手术方式.硬化剂"注射治疗"并发症多,无临床疗效,应予摒弃.Objective To investigate the clinical effect of tension-free hernia repair in treatment of patients with recurrent inguinal hernia who were treated with sclerotherapy and the efficacy of scle- rotherapy for the patients undergoing inguinal hernioplasty. Methods The clinical data of 34 patients who were subjected to sclerotherapy undergoing tension-free inguinal hernioplasty were analyzed retro- spectively analyzed from January 2011 to February 2014. Thirty-three cases were treated with Lichtenstein, and 1 case was given TEP. Results Thirty-four cases were all operated successfully. One case of TEP was converted to Lichtenstein. All the patients were recovered well. The patients were followed up for 1 to 4 years without any recurrence. Conclusions The Lichtenstein has less trauma, simple practice, and lower recurrent rate for the patients with recurrent inguinal hernia and treated with sclerotherapy and can be used as the first choice. The sclerotherapy leads to more complications, and the clinical efficacy was poor.

关 键 词:腹股沟疝 硬化剂注射治疗 无张力疝修补术 

分 类 号:R656.21[医药卫生—外科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象